Your browser doesn't support javascript.
loading
The untapped health and climate potential of cycling in France: a national assessment from individual travel data.
Schwarz, Emilie; Leroutier, Marion; De Nazelle, Audrey; Quirion, Philippe; Jean, Kévin.
Affiliation
  • Schwarz E; Laboratoire MESuRS, Conservatoire national des arts et métiers, Paris, France.
  • Leroutier M; Misum, Stockholm School of Economics, Stockholm, Sweden.
  • De Nazelle A; Centre for Environmental Policy Imperial College London, London, United Kingdom.
  • Quirion P; MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.
  • Jean K; Centre International de Recherche sur l'Environnement et le Développement (CIRED), Centre National de la Recherche Scientifique (CNRS), Nogent-sur-Marne, France.
Lancet Reg Health Eur ; 39: 100874, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38803634
ABSTRACT

Background:

Promoting active modes of transportation such as cycling may generate important public health, economic, and climate mitigation benefits. We aim to assess the mortality and morbidity impacts of cycling in a country with relatively low levels of cycling, France, along with associated monetary benefits. We further assess the potential additional benefits of shifting a portion of short trips from cars to bikes, including projected greenhouse gas emissions savings.

Methods:

Using individual data from a nationally representative mobility survey, we described the French 2019 cycling levels by age and sex. We conducted a burden of disease analysis to assess the incidence of five chronic diseases (breast cancer, colon cancer, cardiovascular diseases, dementia, and type-2 diabetes) and the number of deaths prevented by cycling, based on national incidence and mortality data and dose-response relationships from meta-analyses. We assessed the corresponding direct medical cost savings and the intangible costs prevented based on the value of a statistical life year. Lastly, based on individual simulations, we assessed the likely additional benefits of shifting 25% of short (<5 km) car trips to cycling.

Findings:

The French adult (20-89 years) population was estimated to cycle on average 1 min 17 sec pers-1 day-1 in 2019, with important heterogeneity across sex and age. This yielded benefits of 1,919 (uncertainty interval, UI 1,101-2,736) premature deaths and 5,963 (UI 3,178-8,749) chronic disease cases prevented, with males reaping nearly 75% of these benefits. Direct medical costs prevented were estimated at €191 million (UI 98-285) annually, while the corresponding intangible costs were nearly 25 times higher (€4.8 billion, UI 3.0-6.5). We estimated that on average, €1.02 (UI 0.59-1.62) of intangible costs were prevented for every km cycled. Shifting 25% of short car trips to cycling would yield approximatively a 2-fold increase in deaths prevented, while also generating important CO2 emissions reductions (0.257 MtCO2e, UI 0.231-0.288).

Interpretation:

In a country with a low- to moderate-cycling culture, cycling already generates important public health and health-related economic benefits. Further development of active transportation would increase these benefits while also contributing to climate change mitigation targets.

Funding:

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Key words